These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34709636)

  • 1. Obtention of Dengue Virus Membrane Proteins and Role for Virus Assembly.
    Hsieh SC; Tsai WY; Wang WK
    Methods Mol Biol; 2022; 2409():63-76. PubMed ID: 34709636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope.
    Metz SW; Thomas A; White L; Stoops M; Corten M; Hannemann H; de Silva AM
    Virol J; 2018 Apr; 15(1):60. PubMed ID: 29609659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
    Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies.
    Poddar A; Ramasamy V; Shukla R; Rajpoot RK; Arora U; Jain SK; Swaminathan S; Khanna N
    BMC Biotechnol; 2016 Jun; 16(1):50. PubMed ID: 27301568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient assembly and secretion of recombinant subviral particles of the four dengue serotypes using native prM and E proteins.
    Wang PG; Kudelko M; Lo J; Siu LY; Kwok KT; Sachse M; Nicholls JM; Bruzzone R; Altmeyer RM; Nal B
    PLoS One; 2009 Dec; 4(12):e8325. PubMed ID: 20016834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent Neutralizing Human Monoclonal Antibodies Preferentially Target Mature Dengue Virus Particles: Implication for Novel Strategy for Dengue Vaccine.
    Tsai WY; Chen HL; Tsai JJ; Dejnirattisai W; Jumnainsong A; Mongkolsapaya J; Screaton G; Crowe JE; Wang WK
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30185598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of single-round infectious, chimeric dengue type 1 virus as an antigen for dengue functional antibody assays.
    Yamanaka A; Suzuki R; Konishi E
    Vaccine; 2014 Jul; 32(34):4289-95. PubMed ID: 24950360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly conserved residues in the helical domain of dengue virus type 1 precursor membrane protein are involved in assembly, precursor membrane (prM) protein cleavage, and entry.
    Hsieh SC; Wu YC; Zou G; Nerurkar VR; Shi PY; Wang WK
    J Biol Chem; 2014 Nov; 289(48):33149-60. PubMed ID: 25326389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretion of noninfectious dengue virus-like particles and identification of amino acids in the stem region involved in intracellular retention of envelope protein.
    Purdy DE; Chang GJ
    Virology; 2005 Mar; 333(2):239-50. PubMed ID: 15721358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of virus-neutralizing antibodies and T cell responses by dengue virus type 1 virus-like particles prepared from Pichia pastoris.
    Tang YX; Jiang LF; Zhou JM; Yin Y; Yang XM; Liu WQ; Fang DY
    Chin Med J (Engl); 2012 Jun; 125(11):1986-92. PubMed ID: 22884066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris are Capable of Eliciting Homotypic Domain III-Directed Neutralizing Antibodies.
    Khetarpal N; Shukla R; Rajpoot RK; Poddar A; Pal M; Swaminathan S; Arora U; Khanna N
    Am J Trop Med Hyg; 2017 Jan; 96(1):126-134. PubMed ID: 27821688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pichia pastoris-expressed dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies.
    Mani S; Tripathi L; Raut R; Tyagi P; Arora U; Barman T; Sood R; Galav A; Wahala W; de Silva A; Swaminathan S; Khanna N
    PLoS One; 2013; 8(5):e64595. PubMed ID: 23717637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant-made dengue virus-like particles produced by co-expression of structural and non-structural proteins induce a humoral immune response in mice.
    Ponndorf D; Meshcheriakova Y; Thuenemann EC; Dobon Alonso A; Overman R; Holton N; Dowall S; Kennedy E; Stocks M; Lomonossoff GP; Peyret H
    Plant Biotechnol J; 2021 Apr; 19(4):745-756. PubMed ID: 33099859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stem region of premembrane protein plays an important role in the virus surface protein rearrangement during dengue maturation.
    Zhang Q; Hunke C; Yau YH; Seow V; Lee S; Tanner LB; Guan XL; Wenk MR; Fibriansah G; Chew PL; Kukkaro P; Biukovic G; Shi PY; Shochat SG; Grüber G; Lok SM
    J Biol Chem; 2012 Nov; 287(48):40525-34. PubMed ID: 23035113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an Arylnaphthalene Lignan Derivative as an Inhibitor against Dengue Virus Serotypes 1 to 4 (DENV-1 to -4) Using a Newly Developed DENV-3 Infectious Clone and Replicon.
    Hu M; Li WF; Wu T; Yang Y; Chen G; Chen T; Liu Y; Mei Y; Wu D; Wei Y; Luo T; Zhang HJ; Li YP
    Microbiol Spectr; 2023 Aug; 11(4):e0042323. PubMed ID: 37378517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding Zika Virus Stability and Developing a Chimeric Vaccine through Functional Analysis.
    Xie X; Yang Y; Muruato AE; Zou J; Shan C; Nunes BT; Medeiros DB; Vasconcelos PF; Weaver SC; Rossi SL; Shi PY
    mBio; 2017 Feb; 8(1):. PubMed ID: 28174309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation of dengue virus replicon into virus-like particles by a cell line stably expressing precursor membrane and envelope proteins of dengue virus type 2.
    Lai CY; Hu HP; King CC; Wang WK
    J Biomed Sci; 2008 Jan; 15(1):15-27. PubMed ID: 17768670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesis.
    Dowd KA; Sirohi D; Speer SD; VanBlargan LA; Chen RE; Mukherjee S; Whitener BM; Govero J; Aleshnick M; Larman B; Sukupolvi-Petty S; Sevvana M; Miller AS; Klose T; Zheng A; Koenig S; Kielian M; Kuhn RJ; Diamond MS; Pierson TC
    Proc Natl Acad Sci U S A; 2023 Jan; 120(3):e2218899120. PubMed ID: 36638211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Y-Box Binding Protein 1 Interacts with Dengue Virus Nucleocapsid and Mediates Viral Assembly.
    Diosa-Toro M; Kennedy DR; Chuo V; Popov VL; Pompon J; Garcia-Blanco MA
    mBio; 2022 Feb; 13(1):e0019622. PubMed ID: 35189699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Universal Dengue Vaccine Elicits Neutralizing Antibodies against Strains from All Four Dengue Virus Serotypes.
    Uno N; Ross TM
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33208445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.